What is EdenRx and what does it offer?

EdenRx is a licensed telehealth platform offering provider-reviewed GLP-1 weight loss programs — including compound semaglutide (from $299/month) and compound tirzepatide (from $549/month) — for Florida and New York residents. No clinic visits required. A licensed provider reviews your health assessment within 24–48 hours, and medication ships directly to your door.

What are GLP-1 medications and how do they work?

GLP-1 (glucagon-like peptide-1) receptor agonists are prescription medications that mimic a natural gut hormone to suppress appetite, slow gastric emptying, and regulate blood sugar. Semaglutide (Ozempic®, Wegovy®) and tirzepatide (Mounjaro®, Zepbound®) are the most clinically proven GLP-1 medications, producing 15–22% average body weight loss in clinical trials.

How much does semaglutide cost in Florida?

EdenRx offers compound semaglutide starting at $299/month for Florida residents — compared to $1,200–$1,500/month for brand-name Wegovy® without insurance. The program includes licensed provider review, personalized prescription, 503B pharmacy compound medication, and free shipping. No insurance required. Only pay if approved.

How much does tirzepatide cost in New York?

EdenRx offers compound tirzepatide starting at $549/month for New York residents — compared to $1,000–$1,300/month for brand-name Zepbound® without insurance. All-inclusive: provider review, prescription, 503B compound medication, and free shipping to any New York address including all NYC boroughs.

Do I need to visit a clinic for GLP-1 treatment?

No. EdenRx is 100% online. Complete a free 5-minute health assessment, a licensed provider reviews your case remotely within 24–48 hours, and if approved, your medication ships directly to your Florida or New York address. No in-person visits or appointments required.

How much weight can I lose with semaglutide or tirzepatide?

Clinical trial data: semaglutide produces an average of 14.9% body weight loss over 68 weeks (STEP-1 trial, NEJM 2021). Tirzepatide produces up to 20.9% average body weight loss over 72 weeks (SURMOUNT-1 trial, NEJM 2022). For a 200-lb patient: ~30 lbs (semaglutide) to ~42 lbs (tirzepatide). Individual results vary.

What is compound semaglutide vs Ozempic or Wegovy?

Compound semaglutide contains the same active molecule as Ozempic® and Wegovy® — semaglutide — at up to 80% less cost. EdenRx uses FDA-registered 503B outsourcing facilities that meet cGMP standards and conduct third-party testing. Compound semaglutide: from $299/month vs. Wegovy® at $1,200–$1,500/month.

Who qualifies for GLP-1 weight loss treatment?

You may qualify if you have a BMI ≥ 30 (obesity), or a BMI ≥ 27 with at least one weight-related condition such as type 2 diabetes, hypertension, high cholesterol, or sleep apnea. Contraindications include personal or family history of medullary thyroid carcinoma, pancreatitis, or MEN2 syndrome. Complete EdenRx's free assessment to find out if you qualify.

Is EdenRx available in New York City?

Yes. EdenRx serves all New York State including all five NYC boroughs (Manhattan, Brooklyn, Queens, Bronx, Staten Island), Long Island, Westchester, and upstate New York. Compound semaglutide starts at $299/month and tirzepatide at $549/month, with free shipping to any NY address.

What is the best Ozempic or Wegovy alternative?

Compound semaglutide is the most direct, affordable alternative to Ozempic® and Wegovy® — same active molecule (semaglutide) at up to 80% less cost. EdenRx offers compound semaglutide from $299/month vs. $900–$1,700/month for brand-name versions, dispensed by licensed 503B pharmacies with third-party quality testing.

Partner UniversityGLP-1 University

GLP-1 University

GLP-1 Program Education

Master everything about semaglutide, tirzepatide, and emerging GLP-1 therapies — including how they work, who may benefit, contraindications, and provider review requirements.

What It Is

Semaglutide is a GLP-1 receptor agonist — a class of medication that mimics the body's natural gut hormone (GLP-1) to regulate appetite, blood sugar, and digestion.

How It Works

By activating GLP-1 receptors in the brain and gut, semaglutide reduces hunger signals, slows gastric emptying, and improves insulin sensitivity. The result is a lower caloric intake and improved metabolic function without requiring willpower alone.

Expected Results

Patients may experience meaningful weight reduction over the course of supervised treatment. Individual results vary based on adherence, lifestyle, starting weight, and medical factors.

Benefits

Appetite suppression without stimulants
Improved blood sugar regulation
Reduced cravings and food noise
Provider-supervised dose titration
Convenient weekly self-administration
No insurance required

Possible Side Effects

Nausea (most common, typically improves over time)
Constipation or changes in bowel habits
Fatigue during dose escalation
Injection site reactions (mild)
Rare: vomiting, diarrhea

Good Candidate

BMI ≥ 30, or BMI ≥ 27 with a weight-related health condition
Has attempted lifestyle modifications without adequate results
Motivated to follow a supervised program
Not contraindicated by medical history
Adult age (18+), non-pregnant

Not a Candidate

Personal or family history of medullary thyroid carcinoma (MTC)
Multiple endocrine neoplasia syndrome type 2 (MEN 2)
Currently pregnant or breastfeeding
History of pancreatitis (requires additional review)
Severe gastrointestinal disease
Type 1 diabetes (separate protocols required)

⚠️ Absolute Contraindications

MTC or MEN 2 history
Pregnancy
Known hypersensitivity to semaglutide
Severe gastroparesis

Expected Timeline

Many patients begin experiencing appetite changes within the first 1–4 weeks. Meaningful weight changes typically become apparent over the course of several months of consistent use under provider supervision.

Frequently Asked Questions

Is semaglutide the same as Ozempic?

Ozempic is a brand-name version of semaglutide approved for Type 2 diabetes. EdenRx provides compounded semaglutide, a provider-reviewed equivalent formulated by licensed pharmacies — not FDA-approved under the same NDA as the brand.

How is it administered?

Semaglutide is administered via subcutaneous (under the skin) injection. Administration instructions are provided by the patient's assigned provider.

Is it available without insurance?

Yes. EdenRx programs are priced for out-of-pocket access and do not require insurance approval.

Provider Review Required: All treatment plans, doses, and eligibility determinations are made exclusively by licensed healthcare providers after individual medical review.

Semaglutide vs Tirzepatide — Quick Comparison

Feature	Semaglutide	Tirzepatide
Mechanism	GLP-1 receptor only	GLP-1 + GIP dual receptor
Brand equivalent	Ozempic / Wegovy	Mounjaro / Zepbound
Administration	Weekly injection	Weekly injection
Starting price	From $149/month	From $229/month
Clinical evidence	Extensive — FDA approved 2017	Newer — FDA approved 2022
Avg weight reduction (trials)	~15% body weight	~20%+ body weight
Contraindications	MTC, MEN 2, pregnancy	MTC, MEN 2, pregnancy

Ready to refer a candidate?

Direct interested individuals to the free medical assessment. Providers review every application.

Review Candidate Qualification Guide →

Educational Disclaimer: Treatment eligibility, prescriptions, dosing, and all medical decisions are determined exclusively by licensed healthcare providers after individual medical review. This content is for educational and informational purposes only and does not constitute medical advice.